Relative Strength Chart Celltrion, Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 16/07/2026			5-day change	1st Jan Change
1,75,800.00 ^KRW	+0.06%		+1.56%	+1.98%

14/07	Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar	MT
07/07	Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA	MT

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	CELLTRION, INC.	Other Biotechnology & Medical Research	+0.06%	+1.56%	+1.98%	+4.41%	-20.51%	2.7TCr